| 前收市價 | 0.7000 |
| 開市 | 0.7000 |
| 買盤 | 0.0000 |
| 賣出價 | 1.0500 |
| 拍板 | 5.00 |
| 到期日 | 2024-12-20 |
| 今日波幅 | 0.7000 - 0.7000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 14 |
ZacksPuma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Sales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent quarters. Stiff competition in the target market is also a woe.
ZacksImplied Volatility Surging for Puma Biotechnology (PBYI) Stock Options
Investors need to pay close attention to Puma Biotechnology (PBYI) stock based on the movements in the options market lately.
Insider MonkeyPuma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript May 2, 2024 Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.16. PBYI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name is Camilla, […]
